家 » 全て » 株価予想 » SAB Biotherapeutics Inc. Common Stock 予報

SAB Biotherapeutics Inc. Common Stock 予報: 明日, 週, 月, 5年

更新されました: April 22 · 2026 at 07:03 UTC

From

▼ -1.29%Market Cap $194.12M · Technical analysis Bearish · Focus area Price + volatility

予測の概要

時間枠	予想価格	過去	歴史的	洞察力
明日	$3.78 ▼ -0.88%	昨日	$3.82 ▲ +0.37%	Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.81 and targets $3.78 (-0.88%). The near-term read is downside; watch $3.92 / $3.70 because daily realized volatility is about 4.56%.
Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.81 and targets $3.78 (-0.88%). The near-term read is downside; watch $3.92 / $3.70 because daily realized volatility is about 4.56%.
週	$3.71 ▼ -2.75%	先週	$3.85 ▲ +1.16%	The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.85 to $3.71 (-2.75%). It gives downside momentum context for this stock, so breaks around $3.92 / $3.70 matter more than a single tick.
The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.85 to $3.71 (-2.75%). It gives downside momentum context for this stock, so breaks around $3.92 / $3.70 matter more than a single tick.
月	$3.59 ▼ -5.86%	先月	$3.90 ▲ +2.46%	The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.59 (-5.86%), compared with the live reference near $3.81. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.59 (-5.86%), compared with the live reference near $3.81. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
年	$3.41 ▼ -10.51%	去年	$3.98 ▲ +4.42%	The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.41 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.41 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年	$2.99 ▼ -21.43%	5年前	$4.15 ▲ +9.00%	The 5-year SAB Biotherapeutics Inc. Common Stock view is $2.99 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year SAB Biotherapeutics Inc. Common Stock view is $2.99 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

明日$3.78▼ -0.88%

昨日$3.82▲ +0.37%

Tomorrow's SAB Biotherapeutics Inc. Common Stock (SABS) setup is anchored to $3.81 and targets $3.78 (-0.88%). The near-term read is downside; watch $3.92 / $3.70 because daily realized volatility is about 4.56%.

週$3.71▼ -2.75%

先週$3.85▲ +1.16%

The 7-day SAB Biotherapeutics Inc. Common Stock model moves from $3.85 to $3.71 (-2.75%). It gives downside momentum context for this stock, so breaks around $3.92 / $3.70 matter more than a single tick.

月$3.59▼ -5.86%

先月$3.90▲ +2.46%

The 1-month SAB Biotherapeutics Inc. Common Stock target is $3.59 (-5.86%), compared with the live reference near $3.81. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

年$3.41▼ -10.51%

去年$3.98▲ +4.42%

The 1-year SAB Biotherapeutics Inc. Common Stock scenario points to $3.41 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5年$2.99▼ -21.43%

5年前$4.15▲ +9.00%

The 5-year SAB Biotherapeutics Inc. Common Stock view is $2.99 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

価格表

歴史的予報強気弱気

テクニカル分析

Bearish

強気

中性

弱気

主要な指標

インジケータ	価値	信号
Price	$3.81	Mid
Daily Change	-1.29%	Below
Volatility Cap	20.0%	Mid
Confidence	60%	Below
Data Source	nasdaq-screener	Mid

過去のデータ

Current$3.81

Daily Change-1.29%

Market Cap$194.12M

Sourcenasdaq-screener

Current	$3.81	Daily Change	-1.29%
Market Cap	$194.12M	Source	nasdaq-screener

サポートとレジスタンスのレベル

$3.70Support 1

$3.81現在

$3.92Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

価格マイルストーン

主要なレベルと歴史的背景

Current$3.81Live reference price

Used as the anchor for generated forecast calculations.

Next Month$3.59Model projection-5.86%

Directional scenario based on capped drift.

予測精度

私たちのモデルのパフォーマンス

60%

指向性

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

当社のアルゴリズムは、最新の価格動向、ボラティリティ体制、指標シグナルを使用して毎週再調整されます。精度は時間枠によって異なります。短期的な勢いは長期的な予測よりも信頼性が高くなります。

Short term

60%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

投資シナリオ

今日 $1,000 を SABS に投資した場合

Bullish Scenario

$4.00

+5.00% from current

目標価格$4.00

シナリオUpside momentum

確率52%

Base Scenario

$3.59

-5.86%

目標価格$3.59

シナリオCapped drift

確率60%

Bearish Scenario

$3.62

-5.00% from current

目標価格$3.62

シナリオVolatility drawdown

確率40%

基礎: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

相関行列

30 日ローリング · SABS が他の資産とどのように移動するか

	SABS
SABS	1.00

予測要因

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 38/100

24H drift-0.88%

7D drift-2.75%

30D drift-5.86%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 31/100

1M outlook-5.86%

1Y outlook-10.51%

5Y outlook-21.43%

よくある質問

Q What is the SAB Biotherapeutics Inc. Common Stock (SABS) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), SAB Biotherapeutics Inc. Common Stock is projected near $3.78 versus the current reference around $3.81. That implies a modeled move of -0.88% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for SABS?

The weekly SAB Biotherapeutics Inc. Common Stock model points to $3.71, which maps to an expected drift of -2.75% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the SAB Biotherapeutics Inc. Common Stock 1-month and 1-year targets?

The SAB Biotherapeutics Inc. Common Stock 1-month target is $3.59 (-5.86%), while the 1-year target is $3.41 (-10.51%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the SAB Biotherapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The SAB Biotherapeutics Inc. Common Stock long-horizon scenario sits near $2.99 with a modeled change of -21.43%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are SABS support and resistance zones right now?

For SAB Biotherapeutics Inc. Common Stock, nearest resistance is around $3.70, while nearest support is around $3.92. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the SAB Biotherapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.